03/13/2026
During World Glaucoma Week, we’re reminded that glaucoma can progress without warning signs in its early stages. That’s why early detection is key to preserving vision.
With ZEISS technology, specialists can rely on a more comprehensive patient evaluation: the CIRRUS 6000 for structural analysis of the optic nerve, RNFL, and ganglion cells, and the HFA3 for functional assessment of the visual field and progression tracking. Together, they form a 'structure + function' approach with tools designed to detect, analyze, and monitor glaucoma at every stage.
This is why ZEISS equipment is considered a market leader and, for many specialists, the 'gold standard' in comprehensive glaucoma evaluation.
Want to learn how ZEISS can help you strengthen glaucoma detection in your practice? Contact us to discuss the solutions that can take your diagnosis and follow-up to the next level.